Jenscare receives CE mark for LuX-Valve Plus tricuspid valve replacement system

Regulatory Approvals
Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system, expanding treatment options for patients with severe tricuspid regurgitation. The second-generation...

Jenscare receives CE mark for LuX-Valve Plus tricuspid valve replacement system

Regulatory Approvals
Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system,...

Leo Cancer Care raises $65M Series D to scale upright cancer care platform

Funding
Leo Cancer Care has raised $65 million in an oversubscribed Series D financing to accelerate the commercialization of its integrated upright cancer care platform...

Nyra Medical enrolls first patient in mitral valve repair early feasibility study

Clinical Trials
Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with...

AtaCor enrolls first patient in EV-ICD pivotal study with Abbott

Clinical Trials
AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with...

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Nyra Medical enrolls first patient in mitral valve repair early feasibility study

Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with...

AtaCor enrolls first patient in EV-ICD pivotal study with Abbott

AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with...

First patient enrolled in study of Reflow Medical’s Spur system

Reflow Medical has enrolled the first patient in the DEEPER CHALLENGE study evaluating its Spur Peripheral Retrievable Scaffold System for below-the-knee treatment in patients...

Francis Medical announces publication of VAPOR 2 pivotal trial results

Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology, showcasing highly positive results for...

Innovation

Regulatory Approvals

Jenscare receives CE mark for LuX-Valve Plus tricuspid valve replacement system

Jenscare Scientific has received CE mark approval under the EU Medical Device Regulation (MDR) for its LuX-Valve Plus transvenous tricuspid valve replacement (TTVR) system,...

Leo Cancer Care raises $65M Series D to scale upright cancer care platform

Leo Cancer Care has raised $65 million in an oversubscribed Series D financing to accelerate the commercialization of its integrated upright cancer care platform...

Nyra Medical enrolls first patient in mitral valve repair early feasibility study

Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with...

AtaCor enrolls first patient in EV-ICD pivotal study with Abbott

AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with...

M&A

Archives

Latest articles

Load more

Popular categories

Funding1168Regulatory Approvals1041Innovation657Clinical Trials534Mergers & Acquisitions514GS Funding Tracker56